Status:
COMPLETED
Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Acupuncture
Hip Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
At this time, no formal ERAS (enhanced recovery after surgery) protocol exists for THR that incorporates perioperative acupuncture. Developing, and more importantly, validating a preliminary fast-trac...
Eligibility Criteria
Inclusion
- ASA status of 1 or 2
- Ages 18-80
- Undergoing a total hip replacement
- Ability to follow study protocol
- English-speaking
Exclusion
- Non-English speaking
- Chronic opioids use (6 weeks or more)
- Contraindication to neuraxial anesthesia or peripheral nerve block
- Intending to receive general anesthesia
- Contraindication to intra-op protocol
- Implanted cardiac device (i.e. pacemaker)
- Active ear infection
- Non-native ear, previous scarring or surgery
- Ear gauges or other deforming ear piercing
- Allergy to Nickel
Key Trial Info
Start Date :
July 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2025
Estimated Enrollment :
484 Patients enrolled
Trial Details
Trial ID
NCT05384860
Start Date
July 6 2022
End Date
April 4 2025
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021